9 completed, 8 unknown, 3 recruiting, 3 terminated. 24 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 24 | Completed 9, Unknown 8, Recruiting 3, Terminated 3, Withdrawn 1 |
Follow Statin: new trials by email Literature Review of Statin trials Research Report on Statin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PCSK9 Inhibitor With Statin Therapy for Asymptomatic Intracranial Atherosclerosis Recaticimab and Statin, Statin - Intracranial Atherosclerosis, Intracranial Artery Stenosis | Phase 4 | Recruiting | Peking Union Medical College Hospital | 300 | 2025-11-07 | 2026-06-12 |
| Effect of PCSK9 Inhibitors on Coronary Atherosclerotic Plaques Derived From Optical Coherence Tomography PCSK9 inhibitor, Statin - Coronary Artery Disease, Optical Coherence Tomography | Phase 4 | Recruiting | First Affiliated Hospital of Xinjiang Medical University | 396 | 2024-07-01 | 2024-08-19 |
| Aggressive Risk-Prevention Therapies for Coronary Atherosclerotic Plaque (ART-CAP) Statin, Aspirin tablet, Nexlizet - Coronary Artery Disease, Atherosclerosis | Phase 4 | Withdrawn | University of Louisville | 2024-03-01 | 2025-03-17 | |
| Early Initiation of Tafolecimab for Patients With Acute Coronary Syndromeundergoing Percutaneous Coronary Intervention in Chinese Population Tafolecimab, Cholesterol Absorption Inhibitor, Statin - Acute Coronary Syndrome, Non ST Segment Elevation Acute Coronary Syndrome | Phase 4 | Recruiting | China National Center for Cardiovascular Diseases | 3684 | 2023-11-11 | 2026-10-27 |
| Study on the Composite Endpoint Event of PCSK9 Inhibitor in Patients With Very High Risk of ASCVD and Cancer Evolocumab, Statin - ASCVD, Atherosclerotic Cardiovascular Disease | Phase 4 | Unknown | Xiang Xie | 620 | 2023-08-01 | 2023-08-04 |
| Oral Statins and Protection From Hearing Loss Statin, methylprednisolone, dexamethasone - Sudden Sensorineural Hearing Loss | Phase 4 | Terminated | Northwestern University | 3 | 2023-02-09 | 2026-10-29 |
| Effect of Evolocumab on Chronic Total Occlusions (EVOLO-CTO) PCSK9 inhibitor, Statin - In-stent Restenosis, Major Adverse Cardiovascular Events | Phase 4 | Unknown | Lin Zhao | 200 | 2022-12-15 | 2023-11-13 |
| Effect of PCSK9 Inhibitor on Retinal Microvessels in Patients With Coronary Heart Disease After Intensive Lipid-lowering Therapy Evolocumab combined with statins, Statin - Adverse Effect of Cardiovascular Medications (Diagnosis) | Phase 4 | Unknown | Zibo Central Hospital | 60 | 2022-07-01 | 2023-04-06 |
| Low-dose PCSK9 Inhibitor Combined With Stains on Serum Lipids in Chinese Population With Acute Coronary Syndrome Statin, PCSK9 inhibitor - Acute Coronary Syndrome | Phase 4 | Unknown | The First Affiliated Hospital with Nanjing Medical University | 100 | 2022-04-01 | 2022-03-28 |
| Prognostic Value of Precision Medicine in Patients With MINOCA (PROMISE Trial). Coronary angiography, OCT imaging, Percutaneous coronary intervention (PCI): - Myocardial Infarction With Non-Obstructive Coronary Arteries | Phase 4 | Unknown | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 120 | 2021-07-01 | 2024-07-26 |
| CHOlesterol Lowering and Residual Risk in Type 2 Diabetes Statin, PCSK9 inhibitor, Ezetimibe 10mg - Type 2 Diabetes | Phase 4 | Completed | NYU Langone Health | 151 | 2020-08-12 | 2024-10-17 |
| Atorvastatin Effect on Contrast Induced Nephropathy in Diabetic Patients Undergoing Elective Coronary Intervention Atorvastatin - Coronary Disease | Phase 4 | Completed | Mohamed Abdelfatah | 200 | 2020-03-15 | 2022-02-16 |
| Effect of Lipid Lowering Agents on Diabetic Retinopathy and Cardiovascular Risk of Diabetic Patients Simvastatin 40mg, Fenofibrate 200mg, Omega 3 fatty acid - Diabetic Retinopathy | Phase 4 | Unknown | Alaa Hassan ElBaz | 80 | 2020-02-01 | 2020-01-18 |
| AdminiStration of Statin On Acute Ischemic stRoke patienT Trial Statin - Ischemic Stroke | Phase 4 | Completed | Hyogo Medical University | 270 | 2015-09-01 | 2018-02-27 |
| Assessment of the Effects of Atorvastatin Therapy on Myocardial Deformation Characteristics, in Patients With STEMI Atorvastatin - Myocardial Infarction | Phase 4 | Completed | Penza State University | 200 | 2014-10-01 | 2020-03-24 |
| ANti-Oxidant in Variant Angina (ANOVA) Trial Vitamin C and Vitamin E, Statin, Standard medication for variant angina - Variant Angina | Phase 4 | Terminated | Seoul National University Hospital | 320 | 2014-09-01 | 2026-04-27 |
| Risk Factor Control Before Orthopedic Surgery Metoprolol, Lisinopril, Atorvastatin - Osteoarthritis, Cardiovascular Disease | Phase 4 | Terminated | NYU Langone Health | 198 | 2014-02-01 | 2020-07-27 |
| Rosuvastatin Gel With 1:1 Mixture of Platelet-rich Fibrin and Bone Graft in Mandibular Degree II Furcation Defects Rosuvastatin, platelet rich fibrin - Furcation Defects | Phase 4 | Completed | Government Dental College and Research Institute, Bangalore | 110 | 2013-11-01 | 2015-02-23 |
| The Role of Statins in Preventing Cerebral Vasospasm Secondary to Subarachnoid Hemorrhage statin - Aneurysmal Subarachnoid Hemorrhage | Phase 4 | Unknown | University of Sao Paulo General Hospital | 80 | 2011-04-01 | 2011-05-03 |
| Intensive Statin Therapy in PCI Patient With Acute Coronary Syndrome Atorvastatin, Statin - Myocardial Infarction, Unstable Angina | Phase 4 | Unknown | Xijing Hospital | 300 | 2010-07-01 | 2011-06-14 |
Showing 20 of 24. Sign in to see all of them.
Myocardial Infarction (4) · Coronary Artery Disease (3) · Acute Coronary Syndrome (2) · Angina Pectoris, Variant (2) · Angina, Unstable (2) · Atherosclerosis (2) · Hypertension (2) · Angina, Stable (1) · Cardiovascular Diseases (1) · Coronary Disease (1) · Deafness (1) · Diabetes Mellitus (1) · Diabetes Mellitus, Type 2 (1) · Diabetic Retinopathy (1) · Disease (1)
NYU Langone Health (2) · Alaa Hassan ElBaz (1) · Brasilia Heart Study Group (1) · Chang Gung Memorial Hospital (1) · China National Center for Cardiovascular Diseases (1) · First Affiliated Hospital of Xinjiang Medical University (1) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS (1) · Gachon University Gil Medical Center (1) · Government Dental College and Research Institute, Bangalore (1) · Hyogo Medical University (1) · Lin Zhao (1) · Mohamed Abdelfatah (1) · Northwestern University (1) · Peking Union Medical College Hospital (1) · Peking University First Hospital (1)
China (8) · United States (4) · Brazil (2) · South Korea (2) · Egypt (1) · Italy (1) · Japan (1) · Russia (1) · Taiwan (1)
Jeffrey Berger, MD (2) · Yong Huo, MD (2) · Ahmed Abdel-Galeel, MD (1) · Andrei C Sposito, MD, PhD (1) · Ayman Ibrahem, MD (1) · Dinesh Kalra, MD (1) · Donna Whitlon, Ph.D. (1) · Eberval Figueiredo, PhD (1) · Hyo-Soo Kim, Kim (1) · Lin Zhao, MD (1) · Na-Qiong Wu, Doctor (1) · Nicola Cosentino, MD (1) · Riccardo Gorla, MD (1) · Shinichi Yoshimura (1) · Valentin Oleynikov, prof. (1)
PMID 28304224, PMID 16579514, PMID 17452537, PMID 17548554, PMID 17548555, PMID 17936040, PMID 17975198, PMID 18347202, PMID 18413499, PMID 18452788, PMID 18539753, PMID 18584016, PMID 19101028, PMID 19249441, PMID 20298928, PMID 21543628, PMID 21899409, PMID 24161333, PMID 24489130, PMID 25773607, PMID 26039521, PMID 27846344, PMID 29030478, PMID 29653628, PMID 30403574, PMID 31011477, PMID 31248666, PMID 31504418, PMID 31800032, PMID 31886149, PMID 31887831, PMID 32370478, PMID 34353533, PMID 34453829, PMID 34604796, PMID 34651329, PMID 34695894, PMID 34964815, PMID 35143424, PMID 35508320, PMID 35734824, PMID 35736631, PMID 35760720, PMID 35943472, PMID 36017568, PMID 36031810, PMID 37009731, PMID 37416519, PMID 37666281, PMID 37738517